NEXUS AG (NXU) AI Stock Analysis

• Market Cap: €1.23B
• Dividend Yield: 0.32%
• Average Volume (3M): 995.00
• Price to Earnings (P/E): 35.8
• Beta (1Y): 0.19
• Revenue Growth: 7.41%
• EPS Growth: 26.99%
• Country: DE
• Employees: 1,909
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 0.44
• Shares Outstanding: 17,274,694
• 10 Day Avg. Volume: 193
• 30 Day Avg. Volume: 995
• PEG Ratio: 1.35
• Price to Book (P/B): 4.28
• Price to Sales (P/S): 4.57
• P/FCF Ratio: 29.02
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 68 Neutral
• Price Target: €77.00 ▲(8.15% Upside)

NEXUS AG's overall stock score is driven by its strong financial performance, characterized by consistent revenue growth and robust profitability metrics. However, the technical analysis indicates a neutral trend, and the valuation suggests the stock is relatively expensive with a low dividend yield. These factors combine to provide a balanced outlook for the stock.

Positive Factors

Revenue Growth

Consistent revenue growth indicates a stable demand for NEXUS AG's products and services, supporting long-term business sustainability and market expansion.

Financial Stability

Low leverage enhances financial stability, providing NEXUS AG with the flexibility to invest in growth opportunities and weather economic downturns.

Profitability Metrics

Strong profit margins reflect efficient operations and pricing power, enabling NEXUS AG to reinvest in innovation and maintain competitive advantages.

Negative Factors

Cash Conversion Efficiency

Suboptimal cash conversion could limit NEXUS AG's ability to fund new projects and return capital to shareholders, impacting long-term growth.

Gross Profit Margin Decline

A declining gross profit margin may signal rising costs or pricing pressures, which could erode profitability if not addressed.

Dividend Yield

A low dividend yield may deter income-focused investors, potentially limiting the stock's appeal and affecting market perception.

NEXUS AG Business Overview & Revenue Model

Company Description

Nexus AG develops and sells software and hardware solutions, and provides IT services, primarily for customers in the health care system worldwide. It operates in two divisions, Healthcare Software and Healthcare Services. The company offers information systems, such as NEXUS/HIS and KIS for somatic hospitals; NEXUS/PSYCHIATRY for psychiatric institutions; NEXUS/REHAB for rehabilitation facilities; ITR, a software for rehabilitation, clinics, and hotels with medical care; NEXUS/ARCHIVE and PEGASOS, an archiving and process management system; NEXUS/QM for quality management; NEXUS/INTEGRATION SERVER, an interface management; NEXUS/CLOUD IT, outsourcing solution; NEXUS/EPS, a software solution to supplement SAP personnel management, as well as process and HR consulting in the SAP environment; ifa systems, an ophthalmology software solution; Sophrona solutions, ophthalmology patients and referral program; and NEXUS/DIS, interdisciplinary diagnostic information system. Its information systems also comprise NEXUS/SWISSLAB, a laboratory information system; NEXUS/LAURIS for order communication in diagnostics; NEXUS/PATHOLOGY and NEXUS/CYTOLOGY for pathology and cytology institutes; dc-Pathos and dc-LabMan for pathology and cytology devices; NEXUS/RADIOLOGY, an information and image system for radiology wards and offices; NEXUs/CHILI, for PACS and teleradiology solutions; NEXUS/ASTRAIA for obstetrics and gynecology; NEXUS/SPECIAL DIAGNOSTICS and Clinic WinData for medical specialist diagnostics and device integration; NEXUS/HOME for senior citizen and nursing homes; NEXUS/OUTPATIENT CARE and Asebis, a homecare solution; NEXUS/PAT, an administration system for hospitals; and osoTEC for billing personal and other services. In addition, the company offers SINAPSI, highsystemNET, CREATIV OM, SEXTANT, Emed, NEXUS/EPD, NEXUS/AEMP, NEXUS/SPM, EuroSDS, RVS Software, NEXUS/VITA and TESIS VITA, and NEXUS/ESKULAP. NEXUS AG is headquartered in Donaueschingen, Germany.

How the Company Makes Money

NEXUS AG generates revenue through a diversified business model that includes software licensing, subscription services, and professional consulting. The primary revenue stream comes from the sale of software licenses for its ERP and CRM solutions, which often involve one-time fees and ongoing maintenance contracts. Additionally, the company offers subscription-based cloud services that provide clients with access to its software on a recurring basis, ensuring a steady income flow. Professional services, including implementation, training, and support, also contribute significantly to revenue. Key partnerships with cloud service providers and technology firms enhance NEXUS AG's market reach and capabilities, enabling access to a broader customer base and facilitating co-development of innovative solutions that drive additional revenue opportunities.

NEXUS AG Financial Statement Overview

Summary

NEXUS AG demonstrates a solid financial position with consistent revenue growth and strong profitability metrics. The low leverage and high equity ratio enhance financial stability. While cash flow metrics are positive, there is potential for further improvement in cash conversion efficiency.

Income Statement

NEXUS AG shows a strong financial performance with consistent revenue growth, achieving a 2.26% increase in TTM. The company maintains healthy profit margins, with a TTM net profit margin of 12.10% and an EBIT margin of 16.92%. However, the gross profit margin has decreased compared to previous years, indicating potential cost management challenges.

Balance Sheet

The balance sheet is robust with a low debt-to-equity ratio of 0.072, indicating low leverage and financial stability. The return on equity is solid at 11.91%, reflecting efficient use of equity to generate profits. The equity ratio stands at 61.48%, showcasing a strong equity base relative to total assets.

Cash Flow

Cash flow performance is positive, with a 3.41% growth in free cash flow in TTM. The operating cash flow to net income ratio is 0.51, indicating good cash conversion. However, the free cash flow to net income ratio of 0.83 suggests room for improvement in converting profits into free cash flow.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	274.56M	261.46M	241.46M	209.13M	188.18M	162.94M
Gross Profit	194.82M	223.09M	65.97M	176.46M	159.09M	141.60M
EBITDA	67.04M	61.43M	53.43M	44.81M	40.76M	36.69M
Net Income	34.21M	30.82M	24.03M	19.35M	17.15M	14.92M
Balance Sheet
Total Assets	478.19M	437.73M	411.72M	344.20M	247.34M	223.16M
Cash, Cash Equivalents and Short-Term Investments	144.12M	117.23M	99.00M	110.46M	26.30M	26.45M
Total Debt	19.98M	20.91M	20.25M	18.67M	16.63M	13.15M
Total Liabilities	180.79M	154.77M	153.13M	105.25M	104.94M	99.58M
Stockholders Equity	293.93M	279.24M	255.09M	235.03M	138.79M	120.20M
Cash Flow
Free Cash Flow	51.51M	41.15M	20.95M	28.30M	25.82M	25.60M
Operating Cash Flow	61.02M	51.54M	30.41M	33.88M	31.39M	30.95M
Investing Cash Flow	-12.62M	-30.32M	-17.02M	-98.55M	-21.25M	-22.00M
Financing Cash Flow	-12.91M	-19.63M	-16.72M	57.97M	-11.08M	-16.14M

NEXUS AG Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 71.20
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:NXU, the sentiment is Neutral. The current price of 71.2 is below the 20-day moving average (MA) of 71.30, below the 50-day MA of 71.31, and above the 200-day MA of 70.76, indicating a neutral trend. The MACD of -0.03 indicates Positive momentum. The RSI at 47.84 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for DE:NXU.

NEXUS AG Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
M3V	80 Outperform	€45.86M	10.66	24.14%	3.83%	-5.72%	-25.19%
NXU	68 Neutral	€1.23B	35.84	11.97%	0.32%	7.41%	26.99%
COP	60 Neutral	€1.30B	69.67	2.87%	0.21%	1.16%	-43.53%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

NEXUS AG Corporate Events

NEXUS AG Reports No Share Buybacks in Recent Period

NEXUS AG, a company involved in a share buy-back program, announced that no shares were repurchased between October 20 and October 24, 2025, as part of its 2023 initiative. The total volume of shares bought back so far amounts to 63,432, with transactions conducted via the Frankfurt Stock Exchange’s Xetra platform, facilitated by a commissioned credit institution.

The most recent analyst rating on (DE:NXU) stock is a Hold with a EUR77.00 price target. To see the full list of analyst forecasts on NEXUS AG stock, see the DE:NXU Stock Forecast page.

NEXUS AG Updates on Share Buy-Back Program

NEXUS AG, a company involved in the healthcare software industry, announced that no shares were bought back between October 13 and October 17, 2025, as part of its ongoing share buy-back program initiated in July 2023. The company has repurchased a total of 63,432 shares so far, with transactions conducted exclusively through the Frankfurt Stock Exchange’s Xetra platform, indicating a strategic approach to managing its capital structure.

The most recent analyst rating on (DE:NXU) stock is a Hold with a EUR78.00 price target. To see the full list of analyst forecasts on NEXUS AG stock, see the DE:NXU Stock Forecast page.

NEXUS AG Reports No Share Buybacks in Recent Period

NEXUS AG, a company involved in a share buy-back program, announced that no shares were repurchased between October 6 and October 10, 2025. The program, initiated on July 24, 2023, has so far seen the repurchase of 63,432 shares, conducted via the Frankfurt Stock Exchange’s Xetra platform by a commissioned credit institution.

The most recent analyst rating on (DE:NXU) stock is a Hold with a EUR78.00 price target. To see the full list of analyst forecasts on NEXUS AG stock, see the DE:NXU Stock Forecast page.

NEXUS AG Updates on Share Buy-Back Program

NEXUS AG, a company involved in a share buy-back program, announced that no shares were repurchased between September 29 and October 2, 2025. The program, which began on July 24, 2023, has seen a total of 63,432 shares repurchased, all conducted through the Frankfurt Stock Exchange’s electronic platform, Xetra. This announcement may impact stakeholders’ perception of the company’s financial strategies and market positioning.

The most recent analyst rating on (DE:NXU) stock is a Hold with a EUR78.00 price target. To see the full list of analyst forecasts on NEXUS AG stock, see the DE:NXU Stock Forecast page.

NEXUS AG Reports on Share Buy-Back Program Progress

NEXUS AG, a company involved in a share buy-back program, announced that no shares were repurchased between September 22 and September 26, 2025. The program, initiated on July 24, 2023, has so far resulted in the buyback of 63,432 shares, conducted through the Frankfurt Stock Exchange’s electronic trading platform, Xetra. This activity is part of their ongoing capital market strategies.

The most recent analyst rating on (DE:NXU) stock is a Hold with a EUR78.00 price target. To see the full list of analyst forecasts on NEXUS AG stock, see the DE:NXU Stock Forecast page.

NEXUS AG Reports No Share Buy-Back Activity for September 15-19, 2025

NEXUS AG, a company involved in a share buy-back program, announced that no shares were repurchased between September 15 and September 19, 2025, as part of its 2023 initiative. The total number of shares bought back so far is 63,432, with transactions conducted through the Frankfurt Stock Exchange’s Xetra platform, managed by a commissioned credit institution.

The most recent analyst rating on (DE:NXU) stock is a Hold with a EUR78.00 price target. To see the full list of analyst forecasts on NEXUS AG stock, see the DE:NXU Stock Forecast page.

NEXUS AG Updates on Share Buy-Back Program

NEXUS AG, a company involved in a share buy-back program, announced that no shares were repurchased between September 8 and September 12, 2025. The company has previously disclosed the start of this program on July 24, 2023, and has repurchased a total of 63,432 shares to date. These transactions are conducted through a credit institution on the Frankfurt Stock Exchange’s electronic trading platform, Xetra.

The most recent analyst rating on (DE:NXU) stock is a Hold with a EUR76.00 price target. To see the full list of analyst forecasts on NEXUS AG stock, see the DE:NXU Stock Forecast page.

NEXUS AG Updates on Share Buy-Back Program

NEXUS AG, a company involved in the healthcare software industry, announced that no shares were bought back from August 25 to August 29, 2025, as part of their ongoing share buy-back program initiated on July 24, 2023. The total volume of shares repurchased under this program amounts to 63,432 shares, with transactions conducted exclusively on the Frankfurt Stock Exchange’s electronic platform, Xetra, by a commissioned credit institution.

The most recent analyst rating on (DE:NXU) stock is a Hold with a EUR78.00 price target. To see the full list of analyst forecasts on NEXUS AG stock, see the DE:NXU Stock Forecast page.

NEXUS AG Updates on Share Buy-Back Program

NEXUS AG, a company involved in a share buy-back program, announced that no shares were repurchased between August 18, 2025, and August 22, 2025. The program, which began on July 24, 2023, has so far resulted in the repurchase of 63,432 shares, with transactions conducted exclusively on the Frankfurt Stock Exchange’s electronic platform, Xetra.

The most recent analyst rating on (DE:NXU) stock is a Buy with a EUR79.00 price target. To see the full list of analyst forecasts on NEXUS AG stock, see the DE:NXU Stock Forecast page.

NEXUS AG Updates on Share Buy-Back Program

NEXUS AG, a company involved in capital market activities, announced that during the period from August 11 to August 15, 2025, no shares were repurchased under its share buy-back program initiated on July 24, 2023. The total volume of shares repurchased under this program amounts to 63,432 shares, with transactions conducted exclusively on the Frankfurt Stock Exchange’s electronic trading platform, Xetra. This announcement highlights the company’s ongoing efforts in managing its capital structure, which could influence investor perceptions and market dynamics.

The most recent analyst rating on (DE:NXU) stock is a Hold with a EUR70.00 price target. To see the full list of analyst forecasts on NEXUS AG stock, see the DE:NXU Stock Forecast page.

Nexus AG Faces Squeeze-Out Demand from Project Neptune Bidco GmbH

Nexus AG has received a specified squeeze-out demand from Project Neptune Bidco GmbH, a holding company managed by affiliates of TA Associates Management, L.P. This demand involves the transfer of all shares held by minority shareholders to Project Neptune Bidco GmbH, the majority shareholder, with a cash compensation set at EUR 70.00 per share. The squeeze-out will be effective upon approval at the general meeting scheduled for 25 September 2025 and subsequent registration in the commercial register.

The most recent analyst rating on (DE:NXU) stock is a Hold with a EUR70.00 price target. To see the full list of analyst forecasts on NEXUS AG stock, see the DE:NXU Stock Forecast page.

NEXUS AG Updates on Share Buy-back Program

NEXUS AG, a company involved in a share buy-back program, announced that no shares were repurchased between August 4 and August 8, 2025. The program, which started on July 24, 2023, has so far resulted in the buyback of 63,432 shares. The repurchases are conducted through a credit institution on the Frankfurt Stock Exchange’s electronic trading platform, Xetra. This activity is part of NEXUS AG’s ongoing efforts to manage its share capital and potentially enhance shareholder value.

The most recent analyst rating on (DE:NXU) stock is a Hold with a EUR70.00 price target. To see the full list of analyst forecasts on NEXUS AG stock, see the DE:NXU Stock Forecast page.

NEXUS AG Updates on Share Buy-Back Program

NEXUS AG, a company involved in a share buy-back program, announced that no shares were repurchased between July 28 and August 1, 2025, as part of its 2023 initiative. The total number of shares bought back so far is 63,432, with transactions conducted via the Frankfurt Stock Exchange’s Xetra platform by a commissioned credit institution.

The most recent analyst rating on (DE:NXU) stock is a Hold with a EUR70.00 price target. To see the full list of analyst forecasts on NEXUS AG stock, see the DE:NXU Stock Forecast page.